Cytosine-¹³C,¹⁵N₂

Cat. No.: HY-I0626S1: FAQs
Data Sheet Handling Instructions

Molarity Calculator

Cytosine-¹³C,¹⁵N₂ is the ¹³C and ¹⁵N labeled Cytosine[1]. Cytosine is one of the four main bases found in DNA and RNA. Cytosine modifications exhibit circadian oscillations that are involved in epigenetic diversity and aging[2][3].

For research use only. We do not sell to patients.

Cytosine-<sup>13</sup>C,<sup>15</sup>N<sub>2</sub> Chemical Structure

Cytosine-¹³C,¹⁵N₂ Chemical Structure

CAS No. : 181517-10-2

Size		Stock
50 mg		Get quote
100 mg		Get quote
250 mg		Get quote
Other size		Get quote

Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other Forms of Cytosine-¹³C,¹⁵N₂:

Cytosine In-stock

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description	Cytosine-¹³C,¹⁵N₂ is the ¹³C and ¹⁵N labeled Cytosine[1]. Cytosine is one of the four main bases found in DNA and RNA. Cytosine modifications exhibit circadian oscillations that are involved in epigenetic diversity and aging[2][3].
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Cytosine-¹³C,¹⁵N₂ Related Antibodies
Molecular Weight	113.07
Formula	C₃¹³CH₄N¹⁵N₂O
CAS No.	181517-10-2
SMILES	NC([15N]1)=CC=[15N][13C]1=O
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation	Data Sheet (269 KB) Handling Instructions (2659 KB)
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief] [2]. Maxam AM, et, al. A new method for sequencing DNA. Proc Natl Acad Sci U S A. 1977 Feb;74(2):560-4. [Content Brief] [3]. Oh G, et, al. Cytosine modifications exhibit circadian oscillations that are involved in epigenetic diversity and aging. Nat Commun. 2018 Feb 139(1):644. [Content Brief]